STANDARD BIOTOOLS INC. (LAB) › Shareholders' EquitySTANDARD BIOTOOLS INC. (LAB) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2008: -$158.34M2009: -$173.62M2010: -$189.17M2011: $56.90M2012: $100.66M2013: $96.41M2014: $150.42M2015: $114.90M2016: $53.23M2017: $30.93M2018: $72.12M2019: $153.61M2020: $139.05M2021: $94.60M2022: -$81.47M2023: -$148.05M2024: $471.72M2025: $424.29M$424.29M2008Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$424.29M-10.1%2024$471.72M+418.6%2023-$148.05M-81.7%2022-$81.47M-186.1%2021$94.60M-32.0%2020$139.05M-9.5%2019$153.61M+113.0%2018$72.12M+133.1%2017$30.93M-41.9%2016$53.23M-53.7%2015$114.90M-23.6%2014$150.42M+56.0%2013$96.41M-4.2%2012$100.66M+76.9%2011$56.90M+130.1%2010-$189.17M-9.0%2009-$173.62M-9.7%2008-$158.34M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share